Riluzole Oral Suspension — FDA Drug Shortage
The FDA lists a drug shortage record for Riluzole Oral Suspension (oral suspension) from EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) with status Current. The shortage was first posted on 01/26/2024. Reported reason: Requirements related to complying with good manufacturing practices
Shortage Details
- Status
- Current
- Company
- EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)
- Package NDC
- 70726-0303-1
- Dosage Form
- Oral Suspension
- Presentation
- Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)
- Initial Posting
- 01/26/2024
- Revised Date
Reason
Requirements related to complying with good manufacturing practices